---
title: "ImmunityBio (IBRX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IBRX.US/norm.md"
symbol: "IBRX.US"
name: "ImmunityBio"
parent: "https://longbridge.com/en/quote/IBRX.US.md"
datetime: "2026-05-20T10:57:15.183Z"
locales:
  - [en](https://longbridge.com/en/quote/IBRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IBRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IBRX.US/norm.md)
---

# ImmunityBio (IBRX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.6162 | -0.0634 | -0.0710 | -0.1042 | -0.1520 |
| ROE | 369.38% | 48.36% | 49.13% | 63.71% | 95.99% |
| Revenue | 44.21M | 38.28M | 32.06M | 26.43M | 16.52M |
| Net income | -632.78M | -61.94M | -67.25M | -92.56M | -129.65M |
| Operating income | -69.79M | -64.68M | -55.63M | -71.28M | -64.43M |
| Gross margin | 99.46% | 99.00% | 99.45% | 99.49% | 99.65% |
| Net margin | -1431.44% | -161.80% | -209.77% | -350.26% | -784.92% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 646.64M | 501.90M | 518.99M | 402.08M | 303.76M |
| Leverage | -0.7440 | -1.00 | -0.9915 | -0.7056 | -0.5144 |
| BVPS | -0.8307 | -0.4946 | -0.5323 | -0.6233 | -0.6929 |
| Turnover | 0.2967 | 0.2561 | 0.1869 | 0.1337 | 0.0886 |
| Cash & STI | 380.88M | 242.82M | 257.81M | 153.66M | 61.59M |
| Inv & Rec | 547000.00 | 910000.00 | 6.70M | 6.64M | 8.44M |
| LT assets | 146.07M | 147.54M | 163.08M | 168.03M | 167.05M |
| Net debt | 743.73M | 601.90M | 603.48M | 689.01M | 760.97M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -75.36M | -70.38M | -68.91M | -79.75M | -85.91M |
| Investing CF | -31.65M | 43.57M | -181.36M | -16.14M | 4.13M |
| Financing CF | 223.93M | 54.89M | 173.52M | 172.81M | -982000.00 |
| Free CF | -25.90M | -24.21M | -35.96M | -37.55M | -45.30M |
| OCF coverage | -2836.24% | -3438.10% | -9151.00% | -7349.86% | -7663.25% |
| Repaid & issued | 75.06M | 2.88M | - | - | - |
| CapEx | -1.78M | -903000.00 | -741000.00 | -1.08M | -1.12M |